Medical News Today notes that more than one billion people are expected to be over the age of 60 by 2025, double the present number. The challenge we face: how soon can the scientific and business communities research and commercialize regenerative therapies for age-related degenerative conditions? How soon can we develop and manufacture ways to intervene in the aging process so as to prevent damage and disease from occurring in the first place? This is a race against time to save - and improve - a billion lives over the next few decades. Each year of delay is accompanied by fifty million deaths and untold suffering for hundreds of millions of afflicted people.